ATE251142T1 - Eine kristallmodifikation von celecoxib - Google Patents

Eine kristallmodifikation von celecoxib

Info

Publication number
ATE251142T1
ATE251142T1 AT01106333T AT01106333T ATE251142T1 AT E251142 T1 ATE251142 T1 AT E251142T1 AT 01106333 T AT01106333 T AT 01106333T AT 01106333 T AT01106333 T AT 01106333T AT E251142 T1 ATE251142 T1 AT E251142T1
Authority
AT
Austria
Prior art keywords
celecoxib
crystal modification
ylübenzenesulfo
namide
pyrazol
Prior art date
Application number
AT01106333T
Other languages
English (en)
Inventor
Halit Guenduez
Mehmet Bahar
Mehmet Goektepe
Original Assignee
Fako Ilaclari A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fako Ilaclari A S filed Critical Fako Ilaclari A S
Application granted granted Critical
Publication of ATE251142T1 publication Critical patent/ATE251142T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AT01106333T 2000-06-26 2001-03-15 Eine kristallmodifikation von celecoxib ATE251142T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2000/01872A TR200001872A3 (tr) 2000-06-26 2000-06-26 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem.

Publications (1)

Publication Number Publication Date
ATE251142T1 true ATE251142T1 (de) 2003-10-15

Family

ID=21622570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01106333T ATE251142T1 (de) 2000-06-26 2001-03-15 Eine kristallmodifikation von celecoxib

Country Status (13)

Country Link
US (1) US6391906B2 (de)
EP (1) EP1167355B1 (de)
AT (1) ATE251142T1 (de)
AU (1) AU2001276808A1 (de)
CA (1) CA2350956C (de)
DE (1) DE60100873T2 (de)
EA (1) EA004470B1 (de)
ES (1) ES2206360T3 (de)
HK (1) HK1045155B (de)
IL (1) IL153615A0 (de)
PT (1) PT1167355E (de)
TR (1) TR200001872A3 (de)
WO (1) WO2002000627A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74539C2 (en) * 1999-12-08 2006-01-16 Pharmacia Corp Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
DE10135027A1 (de) * 2001-07-18 2003-02-06 Solvay Pharm Gmbh Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen
US6579988B2 (en) * 2001-09-18 2003-06-17 Onconova Therapeutics, Inc. Processes for the preparation of 1,5-diarylpyrazoles
NZ532346A (en) 2001-09-18 2005-10-28 Onconova Therapeutics Inc Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles
WO2004061433A1 (en) * 2002-12-30 2004-07-22 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20050025791A1 (en) 2002-06-21 2005-02-03 Julius Remenar Pharmaceutical compositions with improved dissolution
AU2003213719A1 (en) 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
AU2002251330A1 (en) * 2002-04-25 2003-11-10 Generics (Uk) Limited Celecoxib forms
WO2003090730A1 (en) * 2002-04-25 2003-11-06 Generics [Uk] Limited Novel crystalline forms of celecoxib and other compounds
PL373807A1 (en) * 2002-05-24 2005-09-19 Pharmacia Corporation Synthesis of diaryl pyrazoles
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
AU2005227745C1 (en) * 2004-04-01 2009-02-26 Zoetis Services Llc Crystalline pyrazole derivative
WO2006024930A1 (en) * 2004-09-01 2006-03-09 Pharmacia & Upjohn Company Llc Novel co-crystals between polyethylene glycols and 5-phenylpyrazolyl-1-benzenesulfonamides
US7727966B2 (en) * 2004-10-28 2010-06-01 Dsm Ip Assets B.V. Stable needle-shaped crystals of natamycin
JP2008528568A (ja) * 2005-01-31 2008-07-31 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Ｉｖ型結晶のセレコキシブ
US20080290719A1 (en) * 2007-05-25 2008-11-27 Kaminsky Robert D Process for producing Hydrocarbon fluids combining in situ heating, a power plant and a gas plant
WO2011055233A2 (en) 2009-11-03 2011-05-12 Actavis Group Ptc Ehf Improved process for preparing celecoxib polymorph
US20110213159A1 (en) * 2010-03-01 2011-09-01 Vamsee Krishna Muppidi Process for preparation of celecoxib crystalline form
CN103524416B (zh) * 2013-10-29 2016-08-17 湖北华世通生物医药科技有限公司 一种塞来昔布新晶型a及其制备方法
CN103539739B (zh) * 2013-10-30 2016-02-10 中美华世通生物医药科技（武汉）有限公司 一种塞来昔布新晶型b及其制备方法
CN103508958A (zh) * 2013-10-30 2014-01-15 中美华世通生物医药科技（武汉）有限公司 一种塞来昔布新晶型c及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604260A (en) 1992-12-11 1997-02-18 Merck Frosst Canada Inc. 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
CA2276945C (en) * 1993-11-30 2006-08-01 G.D. Searle & Co. Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof
CN1174970C (zh) * 1995-05-25 2004-11-10 G·D·瑟尔公司 3-卤代烷基-1h-吡唑的制备方法
AU760888B2 (en) * 1999-01-14 2003-05-22 Merck Frosst Canada & Co. Synthesis of 4-((5-substituted or unsubstituted phenyl) -3-substituted -1H-pyrazol -1-yl) benzenesulfonamides
UA74539C2 (en) * 1999-12-08 2006-01-16 Pharmacia Corp Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)

Also Published As

Publication number Publication date
CA2350956A1 (en) 2001-12-26
HK1045155A1 (en) 2002-11-15
TR200001872A2 (tr) 2002-01-21
AU2001276808A1 (en) 2002-01-08
PT1167355E (pt) 2004-02-27
EA004470B1 (ru) 2004-04-29
IL153615A0 (en) 2003-07-06
CA2350956C (en) 2005-08-23
TR200001872A3 (tr) 2002-01-21
ES2206360T3 (es) 2004-05-16
EP1167355A1 (de) 2002-01-02
EP1167355B1 (de) 2003-10-01
DE60100873T2 (de) 2004-07-22
US6391906B2 (en) 2002-05-21
EA200300067A1 (ru) 2003-06-26
WO2002000627A1 (en) 2002-01-03
US20020016351A1 (en) 2002-02-07
DE60100873D1 (de) 2003-11-06
HK1045155B (zh) 2004-05-28

Similar Documents

Publication Publication Date Title
ATE251142T1 (de) Eine kristallmodifikation von celecoxib
ECSP055594A (es) Nuevos derivados de 2-piridiletilbenzamida
ES2182234T3 (es) Inhibidores de metaloproteasa.
DK1289972T3 (da) Serinproteaseinhibitorer
DE50204803D1 (en) 4-alkylsubstituierte thienyloxy-pyrididne als herbizide
DK1218372T3 (da) Nye heterocykliske forbindelser, der er anvendelige som reversible inhibitorer af cysteinproteaser
SE0100902D0 (sv) Compounds
FI904327A0 (fi) N-substituerad-4-pyrimidinaminer och -pyrimidindiaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ATE332130T1 (de) Fab-i-hemmer
DE60219643D1 (de) Heterozyklische carboxamide und ihre verwendung als fungizide
BR0211652B1 (pt) compostos de piridona e processo para produÇço de composto de piridina.
AR008287A1 (es) Composicion herbicida que comprende compuestos de pirazol sustituidos y metodo de aplicacion de los mismos
MXPA04004806A (es) Derivado de n-heteroarilnicotinamida.
MA26299A1 (fr) Procede pour la surveillance et le controle des thysanopteres
BR0009453B1 (pt) processo para a preparação de um composto.
TR200402776T4 (tr) Nöraminik asit bileşiğinin hidratları ve bunların kristal biçimleri.
DK1637141T3 (da) Stabiliseret proteasesammensætning omfattende en serinprotease, morpholinderivater og reversible inhibitorer af serinproteasen
ATE266026T1 (de) Benzofurancarboxamide und deren therapeutische verwendung
MXPA03012073A (es) Amidoderivados heterociclicos.
EA200100601A1 (ru) Производные 3-(гетероциклил) бензоилпиразолов
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
DK1424329T3 (da) Fremgangsmåde til fremstillingen af 4-(imidazol-1-yl)benzensulfonamid
NO20025101L (no) Nye, heterosykliske forbindelser med antiinflammatorisk aktivitet
DK1499312T3 (da) Anvendelse af hydroxypyridonderivater til sårheling
ATE455100T1 (de) Bipyridinylderivate als hochselektive cyclooxygenase-2-inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties